| Primary |
| Prophylaxis |
48.2% |
| Cataract Operation |
14.7% |
| Postoperative Care |
9.4% |
| Macular Oedema |
4.0% |
| Pain Management |
3.6% |
| Photorefractive Keratectomy |
3.6% |
| Procedural Pain |
2.2% |
| Cystoid Macular Oedema |
1.3% |
| Eye Operation |
1.3% |
| Eye Pain |
1.3% |
| Iritis |
1.3% |
| Retinal Oedema |
1.3% |
| Retinopathy |
1.3% |
| Dry Eye |
0.9% |
| Eye Allergy |
0.9% |
| Eye Inflammation |
0.9% |
| Glaucoma |
0.9% |
| Inflammation |
0.9% |
| Pain |
0.9% |
| Preoperative Care |
0.9% |
|
| Ulcerative Keratitis |
19.1% |
| Visual Acuity Reduced |
14.5% |
| Impaired Healing |
10.5% |
| Vision Blurred |
10.5% |
| Corneal Opacity |
7.2% |
| Anterior Chamber Inflammation |
5.9% |
| Therapeutic Response Delayed |
3.9% |
| Punctate Keratitis |
3.3% |
| Visual Disturbance |
3.3% |
| Macular Oedema |
2.6% |
| Nausea |
2.6% |
| Sinusitis |
2.6% |
| Corneal Abrasion |
2.0% |
| Dizziness |
2.0% |
| Photophobia |
2.0% |
| Post Procedural Complication |
2.0% |
| Weight Increased |
2.0% |
| Condition Aggravated |
1.3% |
| Corneal Epithelium Defect |
1.3% |
| Corneal Oedema |
1.3% |
|
| Secondary |
| Cataract Operation |
62.4% |
| Intraocular Lens Implant |
17.9% |
| Postoperative Care |
4.9% |
| Preoperative Care |
2.8% |
| Prophylaxis |
2.6% |
| Pain Management |
1.4% |
| Macular Oedema |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Eye Irrigation |
0.7% |
| Breast Cancer |
0.5% |
| Cataract |
0.5% |
| Dry Eye |
0.5% |
| Eye Disorder |
0.5% |
| Glaucoma |
0.5% |
| Hypothyroidism |
0.5% |
| Local Anaesthesia |
0.5% |
| Macular Degeneration |
0.5% |
| Nervousness |
0.5% |
| Retinal Disorder |
0.5% |
| Retinal Telangiectasia |
0.5% |
|
| Toxic Anterior Segment Syndrome |
50.0% |
| Off Label Use |
8.2% |
| Medication Error |
7.1% |
| Visual Acuity Reduced |
6.1% |
| Post Procedural Complication |
5.1% |
| Weight Increased |
3.1% |
| Corneal Opacity |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Endophthalmitis |
2.0% |
| Hypersensitivity |
2.0% |
| Platelet Count Decreased |
2.0% |
| Ulcerative Keratitis |
2.0% |
| Alopecia |
1.0% |
| Anaphylactic Shock |
1.0% |
| Bacterial Infection |
1.0% |
| Cardiac Disorder |
1.0% |
| Dizziness |
1.0% |
| Dyspnoea |
1.0% |
| Eye Irritation |
1.0% |
| Headache |
1.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.8% |
| Product Used For Unknown Indication |
22.5% |
| Glaucoma |
9.0% |
| Cataract Operation |
4.0% |
| Prophylaxis |
3.7% |
| Osteoporosis |
3.4% |
| Diabetes Mellitus |
2.9% |
| Hypertension |
2.9% |
| Antibiotic Prophylaxis |
2.6% |
| Uveitis |
2.6% |
| Eye Inflammation |
2.4% |
| Intraocular Pressure Increased |
2.1% |
| Pain |
2.1% |
| Retinal Vasculitis |
2.1% |
| Depression |
1.9% |
| Insomnia |
1.9% |
| Blood Cholesterol Increased |
1.6% |
| Cardiac Disorder |
1.6% |
| Intraocular Pressure Test |
1.6% |
| Constipation |
1.3% |
|
| Visual Acuity Reduced |
13.1% |
| Intraocular Pressure Increased |
9.5% |
| White Blood Cell Count Increased |
9.5% |
| Uveitis |
8.3% |
| Visual Impairment |
7.1% |
| Wound Haemorrhage |
7.1% |
| Cataract |
6.0% |
| Vomiting |
4.8% |
| Weight Decreased |
4.8% |
| Pruritus |
3.6% |
| Ulna Fracture |
3.6% |
| Vision Blurred |
3.6% |
| Cataract Operation |
2.4% |
| Depression |
2.4% |
| Erythema |
2.4% |
| Eye Injury |
2.4% |
| Intraocular Lens Implant |
2.4% |
| Nausea |
2.4% |
| Onychoclasis |
2.4% |
| Palpitations |
2.4% |
|
